AASS and glutaryl-CoA dehydrogenase deficiency: Several preclinical studies already showed the effectiveness of inhibiting AASS to treat glutaric aciduria type I (GA1), another disorder of lysine catabolism,20,21 and during the revision of this manuscript, evidence through knockout of AASS using mouse models has emerged, also supporting this strategy for PDE.22